Press Releases Repligen Corporation

Equities

RGEN

US7599161095

Real-time Estimate Cboe BZX Other stock markets 03:03:02 2024-04-30 pm EDT			5-day change	1st Jan Change
166.2 ^USD	+0.03%		-3.41%	-7.99%

Apr. 08	RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating	MT
Mar. 20	Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Repligen to Report First Quarter 2024 Financial Results	Apr. 17	AQ
Repligen : Investor Presentation April 2024 Presentations	Apr. 01	PU
Repligen Appoints Maggie A. Pax to Board of Directors	Mar. 19	AQ
Repligen: Q4 Earnings Snapshot	Feb. 21	AQ
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	AQ
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results	Feb. 07	AQ
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference	Dec. 19	AQ
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements	Dec. 07	AQ
Repligen Announces Publication of the Company s 2022 Sustainability Report	Nov. 15	AQ
Repligen Announces Publication of the Company’s 2022 Sustainability Report	Nov. 14	AQ
Repligen Corporation to Present at Upcoming Investor Conferences	Nov. 07	AQ
Repligen Launches TangenX SC as First-to-Market Holder-Free Self-Contained TFF Device	Nov. 03	AQ
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device	Nov. 02	AQ
Repligen: Q3 Earnings Snapshot	23-10-31	AQ
Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance	23-10-31	AQ
Repligen to Report Third Quarter 2023 Financial Results	23-10-17	AQ
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer	23-10-02	AQ
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova	23-09-27	AQ
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova	23-09-26	AQ
Repligen Appoints Jason K. Garland as Chief Financial Officer	23-09-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Repligen Corporation

Equities

RGEN

US7599161095

Press Releases

Filters